Matches in Nanopublications for { ?s ?p "[Inactivation and aberrant expression of DLC-1 in human hepatocellular carcinoma (HCC) is frequently associated with hemizygous and homozygous genomic deletion and promoter methylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP231209.RAZLX1dMW07SUa_HNK8qggDWZYEIXXbGfU7JXXQyTPXxw130_assertion description "[Inactivation and aberrant expression of DLC-1 in human hepatocellular carcinoma (HCC) is frequently associated with hemizygous and homozygous genomic deletion and promoter methylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP231209.RAZLX1dMW07SUa_HNK8qggDWZYEIXXbGfU7JXXQyTPXxw130_provenance.
- NP457135.RAFG7PBizL4cXGSI3idvY16_f_PVNN0gMtD9LNQjHN6TA130_assertion description "[Inactivation and aberrant expression of DLC-1 in human hepatocellular carcinoma (HCC) is frequently associated with hemizygous and homozygous genomic deletion and promoter methylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP457135.RAFG7PBizL4cXGSI3idvY16_f_PVNN0gMtD9LNQjHN6TA130_provenance.